• Help us<br><b>lose no child</b> <br>to brain cancer

    Accelerate pediatric brain cancer cures

  • <br><b>FDA APPROVES</b> <br>TOVORAFENIB (DAY101)

    A milestone for children with pediatric low-grade glioma

  • DR. SABINE MUELLER<br><b> A DYNAMIC LEADER</b> <br>IN PEDIATRIC CANCER

    SF Magazine profiles Dr. Mueller’s work as a global innovator in pediatric cancer research

Brain cancer is the deadliest childhood cancer.

The Pediatric Neuro-oncology Consortium (PNOC) brings together the world's best 275+ clinicians and researchers to push for breakthroughs

PNOC is a consortium with a global presence. We have collaborating centers within the United States, Europe, Asia, the Middle East and Australia.

Dedicated to finding cures for pediatric brain cancers, PNOC is translating the latest findings in brain tumor biology into better treatments for children.

These children can't wait. Pediatric brain cancer moves fast. We need to move faster.

We are a GuideStar platinum rated registered 501(c)3.

Give today and join the movement to help accelerate research, clinical trials and cures.

  • VISION

    To lose no child to brain cancer, and to improve the quality of life for those fighting and surviving pediatric brain cancer.

  • MISSION

    To urgently raise funds, resouces and awareness to support PNOC’s research and clinical trials, to ultimately improve outcomes for all children with brain tumors.

  • COLLABORATIVE

    PNOC’s approach is open source and globally collaborative, making research accessible in real time, something never before seen in this field.

BY THE NUMBERS

  • 5,000+

    children in the U.S. are diagnosed each year, of whom more than 500 will die.

  • 40,000+

    children are estimated to be living with a brain tumor in the U.S.

  • 47,000

    years of life are lost each year to pediatric brain cancer.

  • 1%

    pediatric brain cancer only receives ~1% of federal research funding.

Subscribe to receive updates